Steward Partners Investment Advisory, LLC
Position in PTHS — Pelthos Therapeutics Inc.
CIK 1723397
STAMFORD, CT
Position in PTHS
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$40,129
-$19,081 QoQ
Shares Held
1,910
0.0% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 17 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in PTHS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Steward Partners Investment Advisory, LLC holds $46,353,076 across 170 Biotechnology names. PTHS ranks #47 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
|
338,246 | $11,006,524 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
17,863 | $7,976,544 | |
| 3 | ARGX |
Argenx SE
|
9,371 | $6,843,172 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,620 | $3,569,596 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
35,027 | $1,978,675 | |
| 6 | CRMD |
CorMedix Inc.
|
229,465 | $1,558,067 | |
| 7 | SPRY |
ARS Pharmaceuticals, Inc.
|
146,453 | $1,176,017 | |
| 8 | NKTR |
Nektar Therapeutics
|
15,526 | $1,117,095 |
All Filings in PTHS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $40,129 | 1,910 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $59,210 | 1,910 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $53,480 | 1,910 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||